当前位置: X-MOL 学术Lancet › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis.
The Lancet ( IF 168.9 ) Pub Date : 2018-01-01 , DOI: 10.1016/s1473-3099(17)30592-3
Philipp Schuetz , Yannick Wirz , Ramon Sager , Mirjam Christ-Crain , Daiana Stolz , Michael Tamm , Lila Bouadma , Charles E Luyt , Michel Wolff , Jean Chastre , Florence Tubach , Kristina B Kristoffersen , Olaf Burkhardt , Tobias Welte , Stefan Schroeder , Vandack Nobre , Long Wei , Heiner C Bucher , Djillali Annane , Konrad Reinhart , Ann R Falsey , Angela Branche , Pierre Damas , Maarten Nijsten , Dylan W de Lange , Rodrigo O Deliberato , Carolina F Oliveira , Vera Maravić-Stojković , Alessia Verduri , Bianca Beghé , Bin Cao , Yahya Shehabi , Jens-Ulrik S Jensen , Caspar Corti , Jos A H van Oers , Albertus Beishuizen , Armand R J Girbes , Evelien de Jong , Matthias Briel , Beat Mueller

In February, 2017, the US Food and Drug Administration approved the blood infection marker procalcitonin for guiding antibiotic therapy in patients with acute respiratory infections. This meta-analysis of patient data from 26 randomised controlled trials was designed to assess safety of procalcitonin-guided treatment in patients with acute respiratory infections from different clinical settings.

中文翻译:

降钙素原引导的抗生素治疗对急性呼吸道感染死亡率的影响:一项患者水平的荟萃分析。

2017年2月,美国食品和药物管理局批准了血液感染标志物降钙素原用于指导急性呼吸道感染患者的抗生素治疗。这项来自26个随机对照试验的患者数据的荟萃分析旨在评估降钙素指导的治疗在不同临床背景下的急性呼吸道感染患者中的安全性。
更新日期:2017-12-21
down
wechat
bug